These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34708030)

  • 21. Harnessing the type I CRISPR-Cas systems for genome editing in prokaryotes.
    Xu Z; Li Y; Li M; Xiang H; Yan A
    Environ Microbiol; 2021 Feb; 23(2):542-558. PubMed ID: 32510745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR-Enabled Tools for Engineering Microbial Genomes and Phenotypes.
    Tarasava K; Oh EJ; Eckert CA; Gill RT
    Biotechnol J; 2018 Sep; 13(9):e1700586. PubMed ID: 29917318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR-Cas9 Genome Editing Tool for the Production of Industrial Biopharmaceuticals.
    Khan AH; Tye GJ; Noordin R
    Mol Biotechnol; 2020 Sep; 62(9):401-411. PubMed ID: 32749657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Directed Evolution of CRISPR/Cas Systems for Precise Gene Editing.
    Liu R; Liang L; Freed EF; Gill RT
    Trends Biotechnol; 2021 Mar; 39(3):262-273. PubMed ID: 32828556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in genetic technology development of oleaginous yeasts.
    Wen Z; Al Makishah NH
    Appl Microbiol Biotechnol; 2022 Sep; 106(17):5385-5397. PubMed ID: 35930037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The new CRISPR-Cas system: RNA-guided genome engineering to efficiently produce any desired genetic alteration in animals.
    Seruggia D; Montoliu L
    Transgenic Res; 2014 Oct; 23(5):707-16. PubMed ID: 25092533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The era of editing plant genomes using CRISPR/Cas: A critical appraisal.
    Bhat MA; Bhat MA; Kumar V; Wani IA; Bashir H; Shah AA; Rahman S; Jan AT
    J Biotechnol; 2020 Dec; 324():34-60. PubMed ID: 32980369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [CRISPR/Cas system for genome editing in pluripotent stem cells].
    Vasil'eva EA; Melino D; Barlev NA
    Tsitologiia; 2015; 57(1):19-30. PubMed ID: 25872372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Cas system: Toward a more efficient technology for genome editing and beyond.
    Ahmadzadeh V; Farajnia S; Baghban R; Rahbarnia L; Zarredar H
    J Cell Biochem; 2019 Oct; 120(10):16379-16392. PubMed ID: 31219653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Application and optimization of CRISPR/Cas system in bacteria].
    Fu J; Yang F; Xie H; Gu F
    Sheng Wu Gong Cheng Xue Bao; 2019 Mar; 35(3):341-350. PubMed ID: 30912343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Research Progress on Application of CRISPR/Cas Genome Editing Technology in Hematological Diseases -Review].
    Xin LY; Liu AF; Zhong SS; Chen YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1284-8. PubMed ID: 27531817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Versatile and multifaceted CRISPR/Cas gene editing tool for plant research.
    Pandey PK; Quilichini TD; Vaid N; Gao P; Xiang D; Datla R
    Semin Cell Dev Biol; 2019 Dec; 96():107-114. PubMed ID: 31022459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo.
    Salsman J; Masson JY; Orthwein A; Dellaire G
    Curr Gene Ther; 2017; 17(4):263-274. PubMed ID: 29173169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas9 advances engineering of microbial cell factories.
    Jakočiūnas T; Jensen MK; Keasling JD
    Metab Eng; 2016 Mar; 34():44-59. PubMed ID: 26707540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology.
    Zhang D; Li Z; Li JF
    J Genet Genomics; 2016 May; 43(5):251-62. PubMed ID: 27165865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease.
    Hung SSC; McCaughey T; Swann O; Pébay A; Hewitt AW
    Prog Retin Eye Res; 2016 Jul; 53():1-20. PubMed ID: 27181583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome Editing and Its Applications in Model Organisms.
    Ma D; Liu F
    Genomics Proteomics Bioinformatics; 2015 Dec; 13(6):336-44. PubMed ID: 26762955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CRISPR/Cas-based genome editing in Aspergillus niger].
    Zheng X; Zheng P; Sun J
    Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):980-990. PubMed ID: 33783162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR/Cas technology promotes the various application of Dunaliella salina system.
    Feng S; Hu L; Zhang Q; Zhang F; Du J; Liang G; Li A; Song G; Liu Y
    Appl Microbiol Biotechnol; 2020 Oct; 104(20):8621-8630. PubMed ID: 32918585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.